世界の体外診断用医薬品(IVD)品質管理市場(~2027):ソース別(血漿、全血、尿)、技術別、製造業者別、エンドユーザー別

◆英語タイトル:In Vitro Diagnostics (IVD) Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Coagulation), Manufacturer (Third party, OEM), End Users (Hospitals, Lab, Research) - Global Forecast to 2027

MarketsandMarketsが発行した調査報告書(MD4180-23)◆商品コード:MD4180-23
◆発行会社(リサーチ会社):MarketsandMarkets
◆発行日:2023年2月17日
◆ページ数:332
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医薬品
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD4,950 ⇒換算¥643,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥864,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥1,059,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

マーケット&マーケット社の本調査資料では、世界の体外診断用医薬品(IVD)品質管理市場規模が2022年に13億ドルとなり、2027年までに16億ドルに達すると予測しています。さらに、予測期間中に年平均5.4%で拡大すると展望しています。本書では、体外診断用医薬品(IVD)品質管理の世界市場について詳しく分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品・サービス別(品質管理用製品、データ管理ソリューション、品質保証サービス)分析、技術別(免疫化学、臨床化学、分子診断、微生物学、その他)分析、製造業者別(サードパーティ、OEM)分析、エンドユーザー別(病院、臨床検査室、学術・研究機関、その他)分析、地域別(北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ)分析、競争状況、企業情報などの項目を整理しています。また、Bio-Rad Laboratories、Inc. (US)、Randox Laboratories Ltd. (UK)、Thermo Fisher Scientific、Inc. (US)、LGC Limited (UK)、Abbott Laboratories (US)などの企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の体外診断用医薬品(IVD)品質管理市場規模:製品・サービス別
- 品質管理用製品の市場規模
- データ管理ソリューションの市場規模
- 品質保証サービスの市場規模
・世界の体外診断用医薬品(IVD)品質管理市場規模:技術別
- 免疫化学における市場規模
- 臨床化学における市場規模
- 分子診断における市場規模
- 微生物学における市場規模
- その他における市場規模
・世界の体外診断用医薬品(IVD)品質管理市場規模:製造業者別
- サードパーティにおける市場規模
- OEMにおける市場規模
・世界の体外診断用医薬品(IVD)品質管理市場規模:エンドユーザー別
- 病院における市場規模
- 臨床検査室における市場規模
- 学術・研究機関における市場規模
- その他における市場規模
・世界の体外診断用医薬品(IVD)品質管理市場規模:地域別
- 北米の体外診断用医薬品(IVD)品質管理市場規模
- ヨーロッパの体外診断用医薬品(IVD)品質管理市場規模
- アジア太平洋の体外診断用医薬品(IVD)品質管理市場規模
- 中南米の体外診断用医薬品(IVD)品質管理市場規模
- 中東・アフリカの体外診断用医薬品(IVD)品質管理市場規模
・競争状況
・企業情報
❖ レポートの概要 ❖

“The global IVD quality control market is projected to reach USD 1.6 billion by 2027 from USD 1.3 billion in 2022, at a CAGR of 5.4% during the forecast period. ”
The competitive landscape includes the analysis of the key growth strategies adopted by major players between January 2019 and January 2023. Players in the global IVD Quality Control market have employed various strategies to expand their global footprint and increase their market shares such as agreements, divestitures, expansions, and acquisitions.

“The product & service segment holds the highest share of the total IVD quality control market during the forecast period. ”
The quality control products segment accounted for the largest share of the IVD quality control market in 2021. The increasing number of accredited laboratories to ensure the accuracy of diagnostic test results are driving the growth of the IVD quality control products market.

“Serum/plasma-based controls segment accounted for the highest share for the Product and Services in total IVD quality control market during the forecast period. ”
Serum/plasma-based IVD quality controls are highly preferred by laboratories, as they are more stable after manipulation, such as freezing, storage, and lyophilization.; this segment accounted for the largest share of the quality control products market in 2021. The increasing number of IVD tests and the rising need for accuracy, reliability, and reproducibility of test results are the key factors driving the growth of the IVD quality control products market

“Third-party controls dominated the Manufacturer segmented of IVD quality control market”
Based on manufacturer, the IVD quality control market is segmented into OEM controls and third-party controls. The third-party controls segment accounted for the largest share of the manufacturer segment in the global IVD quality control market in 2021. The independent controls segment is expected to grow at the highest CAGR in the third-party controls market during the forecast period. The growth of this segment is attributed to the fact that regulatory bodies recommend independent controls.

“During the forecast period, hospitals accounted for the highest share in the end users segment of the global IVD quality control market. ”
The end users of IVD quality controls included in this report are research & academic institutes, hospitals, clinical laboratories, and other end users (blood banks, local public health laboratories, home health agencies, and nursing homes). The hospitals segment accounted for the largest share of the IVD quality control market in 2021, and Clinical laboratories are estimated to be the fastest-growing end-user segment in this market. The increasing burden of infectious diseases across the globe and the growing volume of genetic testing are the key factors driving the growth of this end-user segment.

“North America is will account for the highest share in the global IVD quality control market ”
By Region, the global IVD quality control market accounted in this report is divided into five major regions—North America, Europe, Latin America, the Asia Pacific, and the Middle East & Africa. In 2021, North America accounted for the largest share of the global IVD quality control market, followed by Europe. In North America, US accounted for the largest share folowed by Canada. The APAC region has the highest CAGR of the global IVD quality control market.

Key players in the IVD quality control Market
Some of the key players in the market include Bio-Rad Laboratories, Inc. (US), Randox Laboratories Ltd. (UK), Thermo Fisher Scientific, Inc. (US), LGC Limited (UK), and Abbott Laboratories (US). Other prominent payers in the market include Roche Diagnostics (Switzerland), Siemens Healthineers (Germany), Danaher Corporation (US), Fortress Diagnostics (UK), SERO AS (US), Sysmex Corporation (Japan), Ortho-Clinical Diagnostics (US), Helena Laboratories Corporation (US), Quidel Corporation (US), Sun Diagnostics, LLC (US), Seegene Inc. (South Korea), ZeptoMetrix Corporation (US), Qnostics (UK), Bio-Techne Corporation (US), Microbiologics (US), Microbix Biosystems (Canada), Streck, Inc. (US), Alpha-Tec Systems (US), Maine Molecular Quality Controls, Inc. (US), and Grifols, S.A. (Spain). These players aim to secure higher market shares through strategies such as product launches, expansions, agreements, and acquisitions.

Break of primary participants was as mentioned below:
• By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
• By Designation – C-level–30%, Director-level–50%, Others–20%
• By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%

Research Coverage:
The market study covers the endoscopy equipment market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by product, by application, by end user, and by region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report
The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the IVD Quality Control market and its segments. This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies. The report will also help stakeholders in understanding the pulse of the market and gaining information on key market drivers, restraints, opportunities, and challenges.

❖ レポートの目次 ❖

1 INTRODUCTION 26
1.1 STUDY OBJECTIVES 26
1.2 MARKET DEFINITION 26
1.2.1 INCLUSIONS AND EXCLUSIONS 27
1.2.2 MARKETS COVERED 28
1.2.3 YEARS CONSIDERED 29
1.3 CURRENCY 29
TABLE 1 EXCHANGE RATES UTILIZED FOR CONVERSION TO USD 29
1.4 STAKEHOLDERS 30
1.5 SUMMARY OF CHANGES 30
1.5.1 REFINEMENTS IN SEGMENTS OF GLOBAL IVD QUALITY CONTROLS MARKET 30
1.5.2 UPDATED FINANCIAL INFORMATION/PRODUCT PORTFOLIOS OF PLAYERS 30
1.5.3 UPDATED MARKET DEVELOPMENTS OF PROFILED PLAYERS 31
1.5.4 ADDITION OF RECESSION IMPACT 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
FIGURE 1 RESEARCH DESIGN 32
2.1.1 SECONDARY DATA 32
2.1.1.1 Key data from secondary sources 33
2.1.2 PRIMARY DATA 34
2.1.2.1 Primary sources 34
2.1.2.2 Key data from primary sources 35
2.1.2.3 Key industry insights 35
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 36
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 36
2.2 MARKET SIZE ESTIMATION 37
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 37
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION: BIO-RAD LABORATORIES, INC. 38
FIGURE 6 REVENUE ANALYSIS OF TOP FIVE COMPANIES: IVD QUALITY CONTROLS MARKET (2021) 38
FIGURE 7 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF IVD QUALITY CONTROLS MARKET (2022–2027) 40
FIGURE 8 CAGR PROJECTIONS 40
FIGURE 9 TOP-DOWN APPROACH 41

2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 10 MARKET DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ESTIMATION 43
2.5 ASSUMPTIONS 43
2.6 RISK ASSESSMENT 44
TABLE 2 RISK ASSESSMENT: IVD QUALITY CONTROLS MARKET 44
2.7 LIMITATIONS 44
2.7.1 METHODOLOGY-RELATED LIMITATIONS 44
2.7.2 SCOPE-RELATED LIMITATIONS 44
2.8 IMPACT OF RECESSION 44
3 EXECUTIVE SUMMARY 45
FIGURE 11 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2022 VS. 2027 (USD MILLION) 45
FIGURE 12 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 46
FIGURE 13 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2022 VS. 2027 (USD MILLION) 46
FIGURE 14 THIRD-PARTY CONTROLS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 47
FIGURE 15 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 48
FIGURE 16 IVD QUALITY CONTROLS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 49
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF IVD QUALITY CONTROLS MARKET 50
4 PREMIUM INSIGHTS 51
4.1 IVD QUALITY CONTROLS MARKET OVERVIEW 51
FIGURE 18 GROWING ADOPTION OF THIRD-PARTY CONTROLS AND INCREASING DEMAND FOR EXTERNAL QUALITY ASSESSMENT TO DRIVE MARKET 51
4.2 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY AND COUNTRY (2021) 52
FIGURE 19 IMMUNOCHEMISTRY SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 52
4.3 IVD QUALITY CONTROLS MARKET: REGIONAL MIX (2022–2027) 53
FIGURE 20 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 53
4.4 IVD QUALITY CONTROLS MARKET: DEVELOPED VS. DEVELOPING MARKETS 53
FIGURE 21 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH FROM 2022 TO 2027 53
4.5 IVD QUALITY CONTROLS MARKET: GEOGRAPHIC MIX 54
FIGURE 22 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 23 IVD QUALITY CONTROLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 MARKET DRIVERS 56
5.2.1.1 Increasing number of accredited clinical laboratories 56
FIGURE 24 NUMBER OF LABORATORIES WITH CLIA ACCREDITATION, BY ORGANIZATION (2022) 56
5.2.1.2 Growing adoption of third-party quality controls 57
5.2.1.3 Rising demand for external quality assessment support 57
5.2.1.4 Rising geriatric population and subsequent growth in prevalence of chronic and infectious diseases 58
TABLE 3 ESTIMATED INCREASE IN GERIATRIC POPULATION, BY REGION (2019–2050) 58
FIGURE 25 ESTIMATED DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045 (MILLION) 59
FIGURE 26 GLOBAL CANCER INCIDENCE, 2018–2040 (MILLION) 59
5.2.1.5 Increasing adoption of POC instruments in developed regions 60
TABLE 4 MARKET DRIVERS: IMPACT ANALYSIS 60
5.2.2 MARKET RESTRAINTS 60
5.2.2.1 Additional costs and budget constraints in hospitals and laboratories 60
5.2.2.2 Unfavorable reimbursement scenario for IVD tests 61
TABLE 5 MARKET RESTRAINTS: IMPACT ANALYSIS 61
5.2.3 MARKET OPPORTUNITIES 61
5.2.3.1 Rising demand for multianalyte controls 61
TABLE 6 MARKET OPPORTUNITIES: IMPACT ANALYSIS 61
5.2.4 MARKET CHALLENGES 62
5.2.4.1 Stringent product approval process 62
5.2.4.2 Lack of regulations for clinical laboratory accreditation in several emerging countries 62
TABLE 7 MARKET CHALLENGES: IMPACT ANALYSIS 62
5.3 INDUSTRY TRENDS 63
5.3.1 LYOPHILIZED/FREEZE-DRIED CONTROLS 63
TABLE 8 LYOPHILIZED OR FREEZE-DRIED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 63
5.3.2 TRENDS ON ANALYTE SOURCE: HUMAN VS. ANIMAL ORIGIN 63
5.3.3 CONSOLIDATION OF LABORATORIES 64
5.4 VALUE CHAIN ANALYSIS 64
FIGURE 27 IVD QUALITY CONTROLS MARKET: VALUE CHAIN ANALYSIS 64
5.5 SUPPLY CHAIN ANALYSIS 65
FIGURE 28 IVD QUALITY CONTROLS MARKET: SUPPLY CHAIN ANALYSIS 66
5.6 ECOSYSTEM MARKET MAP 66
FIGURE 29 IVD QUALITY CONTROLS MARKET: ECOSYSTEM MARKET MAP 67
5.7 PORTER’S FIVE FORCES ANALYSIS 67
TABLE 9 PORTER’S FIVE FORCES ANALYSIS 67
5.7.1 INTENSITY OF COMPETITIVE RIVALRY 68
5.7.2 BARGAINING POWER OF SUPPLIERS 68
5.7.3 BARGAINING POWER OF BUYERS 68
5.7.4 THREAT OF SUBSTITUTES 68
5.7.5 THREAT OF NEW ENTRANTS 69
5.8 REGULATORY ANALYSIS 69
5.8.1 NORTH AMERICA 69
5.8.1.1 US 69
TABLE 10 US: CLASSIFICATION OF QUALITY CONTROL MATERIAL 70
TABLE 11 US: TIME, COST, AND COMPLEXITY OF REGISTRATION 70
5.8.1.2 Canada 71
TABLE 12 CANADA: CLASSIFICATION OF IVD PRODUCTS 71
TABLE 13 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION 71
5.8.2 EUROPE 71
TABLE 14 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES 72
TABLE 15 EUROPE: TIME, COST, AND COMPLEXITY OF REGISTRATION 72
5.8.3 ASIA PACIFIC 73
5.8.3.1 Japan 73
TABLE 16 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION 73
5.8.3.2 China 74
TABLE 17 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION 74
5.8.3.3 India 74
TABLE 18 INDIA: TIME, COST, AND COMPLEXITY OF REGISTRATION 75
5.9 PATENT ANALYSIS 75
5.9.1 PATENT PUBLICATION TRENDS FOR IVD QUALITY CONTROLS 75
FIGURE 30 PATENT PUBLICATION TRENDS (2012–2022) 75
5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO IVD QUALITY CONTROL 76
FIGURE 31 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR IVD QUALITY CONTROL PATENTS (2012–2022) 76
5.9.3 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES/REGIONS) FOR PATENTS IN IVD QUALITY CONTROLS MARKET 76
FIGURE 32 JURISDICTION ANALYSIS: TOP APPLICANT (COUNTRIES/REGIONS) FOR PATENTS IN IVD QUALITY CONTROL (2012–2022) 77
5.10 TECHNOLOGY ANALYSIS 77
5.10.1 KEY TECHNOLOGIES 78
5.10.1.1 Analyte extraction 78
5.10.1.1.1 Specimen pooling 78
5.10.1.1.2 Human monoclonals 78
5.10.1.2 Specimen processing 78
5.10.1.2.1 Inactivation 78
5.10.1.2.2 Dilution 79
5.10.1.3 Preservation 79
5.10.2 ADJACENT TECHNOLOGIES 79
5.10.2.1 Sensor-based quality control 79

5.10.3 COMPLEMENTARY TECHNOLOGIES 79
5.10.3.1 Storage 79
5.10.3.2 Transport 80
5.10.3.3 Temperature control 80
5.10.3.4 Temperature monitoring 80
6 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE 81
6.1 INTRODUCTION 82
TABLE 19 IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 82
6.2 QUALITY CONTROL PRODUCTS 82
TABLE 20 IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 83
TABLE 21 IVD QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 83
6.2.1 SERUM/PLASMA-BASED CONTROLS 84
6.2.1.1 Greater stability and accuracy of diagnostic test results to increase demand for serum/plasma-based controls 84
TABLE 22 SERUM/PLASMA-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 84
TABLE 23 SERUM/PLASMA-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 85
6.2.2 WHOLE BLOOD-BASED CONTROLS 85
6.2.2.1 Rising need to ensure high-quality clinical test results to drive market 85
TABLE 24 WHOLE BLOOD-BASED QUALITY CONTROLS OFFERED BY KEY MARKET PLAYERS 86
TABLE 25 WHOLE BLOOD-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 87
6.2.3 URINE-BASED CONTROLS 87
6.2.3.1 Growing incidence of kidney diseases to drive demand for urine-based controls 87
TABLE 26 URINE-BASED IVD CONTROLS OFFERED BY KEY MARKET PLAYERS 88
TABLE 27 URINE-BASED QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 89
6.2.4 OTHER CONTROLS 89
TABLE 28 OTHER CONTROLS OFFERED BY KEY MARKET PLAYERS 90
TABLE 29 OTHER QUALITY CONTROL PRODUCTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 91
6.3 DATA MANAGEMENT SOLUTIONS 91
6.3.1 RISING FOCUS ON IMPROVING ANALYTICAL PERFORMANCE OF CLINICAL LABORATORIES TO SUPPORT MARKET GROWTH 91
TABLE 30 DATA MANAGEMENT SOLUTIONS OFFERED BY KEY MARKET PLAYERS 92
TABLE 31 IVD DATA MANAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 93

6.4 QUALITY ASSURANCE SERVICES 94
6.4.1 GROWING NEED FOR PERFORMANCE ASSESSMENT OF CLINICAL LABORATORIES TO INCREASE DEMAND FOR QUALITY ASSURANCE SERVICES 94
TABLE 32 QUALITY ASSURANCE SERVICES OFFERED BY KEY MARKET PLAYERS 94
TABLE 33 IVD QUALITY ASSURANCE SERVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 95
7 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY 96
7.1 INTRODUCTION 97
TABLE 34 IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 97
7.2 IMMUNOCHEMISTRY 98
7.2.1 FOCUS ON MONITORING PRECISION OF IMMUNOASSAY TESTS TO DRIVE ADOPTION OF IMMUNOASSAY CONTROLS 98
TABLE 35 QUALITY CONTROLS FOR IMMUNOCHEMISTRY OFFERED BY KEY MARKET PLAYERS 98
TABLE 36 IVD QUALITY CONTROLS MARKET FOR IMMUNOCHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION) 99
7.3 CLINICAL CHEMISTRY 100
7.3.1 RISING INCIDENCE OF LIFESTYLE DISEASES PROVIDES OPPORTUNITIES FOR MARKET GROWTH 100
TABLE 37 QUALITY CONTROLS FOR CLINICAL CHEMISTRY OFFERED BY KEY MARKET PLAYERS 100
TABLE 38 IVD QUALITY CONTROLS MARKET FOR CLINICAL CHEMISTRY, BY COUNTRY, 2020–2027 (USD MILLION) 101
7.4 MOLECULAR DIAGNOSTICS 101
7.4.1 GROWING INCIDENCE OF INFECTIOUS DISEASES TO DRIVE DEMAND FOR MOLECULAR DIAGNOSTIC CONTROLS 101
TABLE 39 QUALITY CONTROLS FOR MOLECULAR DIAGNOSTICS OFFERED BY KEY MARKET PLAYERS 102
TABLE 40 IVD QUALITY CONTROLS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 103
7.5 MICROBIOLOGY 104
7.5.1 INCREASING ADOPTION OF AUTOMATED CLINICAL MICROBIOLOGY TESTING INSTRUMENTS TO SUPPORT MARKET GROWTH 104
TABLE 41 QUALITY CONTROLS FOR MICROBIOLOGY OFFERED BY KEY MARKET PLAYERS 104
TABLE 42 IVD QUALITY CONTROLS MARKET FOR MICROBIOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 105
7.6 HEMATOLOGY 105
7.6.1 NEED FOR ACCURACY IN HEMATOLOGICAL TEST RESULTS TO DRIVE RELIANCE ON HEMATOLOGY QUALITY CONTROLS 105
TABLE 43 QUALITY CONTROLS FOR HEMATOLOGY OFFERED BY KEY MARKET PLAYERS 106
TABLE 44 IVD QUALITY CONTROLS MARKET FOR HEMATOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 107

7.7 COAGULATION AND HEMOSTASIS 107
7.7.1 GROWING NUMBER OF CARDIOVASCULAR SURGERIES TO DRIVE DEMAND FOR COAGULATION AND HEMOSTASIS TESTING 107
TABLE 45 QUALITY CONTROLS FOR COAGULATION AND HEMOSTASIS OFFERED BY KEY MARKET PLAYERS 108
TABLE 46 IVD QUALITY CONTROLS MARKET FOR COAGULATION AND HEMOSTASIS, BY COUNTRY, 2020–2027 (USD MILLION) 109
7.8 OTHER TECHNOLOGIES 110
TABLE 47 QUALITY CONTROLS FOR OTHER TECHNOLOGIES OFFERED BY KEY MARKET PLAYERS 110
TABLE 48 IVD QUALITY CONTROLS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2020–2027 (USD MILLION) 111
8 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE 112
8.1 INTRODUCTION 113
TABLE 49 IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 113
8.2 THIRD-PARTY CONTROLS 113
TABLE 50 IVD THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 114
TABLE 51 IVD THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 114
8.2.1 INDEPENDENT CONTROLS 115
8.2.1.1 Provide unbiased and independent performance assessment for analytical processes 115
TABLE 52 INDEPENDENT CONTROLS OFFERED BY KEY MARKET PLAYERS 115
TABLE 53 INDEPENDENT THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 116
8.2.2 INSTRUMENT-SPECIFIC CONTROLS 117
8.2.2.1 Designed to evaluate and monitor performance of instruments 117
TABLE 54 INSTRUMENT-SPECIFIC CONTROLS OFFERED BY KEY MARKET PLAYERS 117
TABLE 55 INSTRUMENT-SPECIFIC THIRD-PARTY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 118
8.3 ORIGINAL EQUIPMENT MANUFACTURER CONTROLS 118
8.3.1 OEM CONTROLS TO WITNESS LOWER ADOPTION AS THEY ARE LESS SENSITIVE TO QC-RELATED ISSUES 118
TABLE 56 OEM CONTROLS OFFERED BY KEY MARKET PLAYERS 119
TABLE 57 IVD OEM CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 120
9 IVD QUALITY CONTROLS MARKET, BY END USER 121
9.1 INTRODUCTION 122
TABLE 58 IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
9.2 HOSPITALS 122
9.2.1 LARGE VOLUME OF IVD PROCEDURES PERFORMED TO DRIVE MARKET 122
TABLE 59 IVD QUALITY CONTROLS MARKET FOR HOSPITALS, BY COUNTRY, 2020–2027 (USD MILLION) 123
9.3 CLINICAL LABORATORIES 124
9.3.1 GROWING NUMBER OF ACCREDITED LABORATORIES TO DRIVE MARKET 124
TABLE 60 IVD QUALITY CONTROLS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 125
9.4 ACADEMIC AND RESEARCH INSTITUTES 125
9.4.1 RISING FOCUS ON ACCURATE RESEARCH RESULTS TO SUPPORT MARKET GROWTH 125
TABLE 61 IVD QUALITY CONTROLS MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 126
9.5 OTHER END USERS 127
TABLE 62 IVD QUALITY CONTROLS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 127
10 IVD QUALITY CONTROLS MARKET, BY REGION 128
10.1 INTRODUCTION 129
TABLE 63 IVD QUALITY CONTROLS MARKET, BY REGION, 2020–2027 (USD MILLION) 129
TABLE 64 IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 130
10.2 NORTH AMERICA 130
FIGURE 33 NORTH AMERICA: IVD QUALITY CONTROLS MARKET SNAPSHOT 131
10.2.1 NORTH AMERICA: RECESSION IMPACT 132
TABLE 65 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 66 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 132
TABLE 67 NORTH AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 133
TABLE 68 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 133
TABLE 69 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 133
TABLE 70 NORTH AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 134
TABLE 71 NORTH AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 134
10.2.2 US 134
10.2.2.1 High healthcare expenditure to propel market growth 134
TABLE 72 US: KEY MACROINDICATORS 135
TABLE 73 US: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 135
TABLE 74 US: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 135
TABLE 75 US: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 136
TABLE 76 US: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 136
TABLE 77 US: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 136
TABLE 78 US: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 137
10.2.3 CANADA 137
10.2.3.1 Government initiatives to support market growth 137
TABLE 79 CANADA: KEY MACROINDICATORS 138
TABLE 80 CANADA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 138
TABLE 81 CANADA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 138
TABLE 82 CANADA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 139
TABLE 83 CANADA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 139
TABLE 84 CANADA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 139
TABLE 85 CANADA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 140
10.3 EUROPE 140
10.3.1 EUROPE: RECESSION IMPACT 140
TABLE 86 EUROPE: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 87 EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 141
TABLE 88 EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 142
TABLE 89 EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 142
TABLE 90 EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 142
TABLE 91 EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 143
TABLE 92 EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 143
10.3.2 GERMANY 143
10.3.2.1 Rising volume of high-quality tests performed to support market growth 143
TABLE 93 GERMANY: KEY MACROINDICATORS 144
TABLE 94 GERMANY: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 144
TABLE 95 GERMANY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 144
TABLE 96 GERMANY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 145
TABLE 97 GERMANY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 145
TABLE 98 GERMANY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 145
TABLE 99 GERMANY: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 146

10.3.3 FRANCE 146
10.3.3.1 Increasing prevalence of infectious diseases and growing demand for early diagnosis to drive market 146
TABLE 100 FRANCE: KEY MACROINDICATORS 146
TABLE 101 FRANCE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 147
TABLE 102 FRANCE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 147
TABLE 103 FRANCE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 147
TABLE 104 FRANCE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 148
TABLE 105 FRANCE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 148
TABLE 106 FRANCE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 148
10.3.4 UK 149
10.3.4.1 Growth in life sciences industry and increasing research to drive market 149
TABLE 107 UK: KEY MACROINDICATORS 149
TABLE 108 UK: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 150
TABLE 109 UK: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 150
TABLE 110 UK: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 150
TABLE 111 UK: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 151
TABLE 112 UK: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 151
TABLE 113 UK: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 151
10.3.5 ITALY 152
10.3.5.1 Growing disease prevalence to drive demand for better and more accurate disease diagnosis 152
TABLE 114 ITALY: KEY MACROINDICATORS 152
TABLE 115 ITALY: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 152
TABLE 116 ITALY: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 153
TABLE 117 ITALY: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 153
TABLE 118 ITALY: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 153
TABLE 119 ITALY: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 154
TABLE 120 ITALY: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 154

10.3.6 SPAIN 154
10.3.6.1 Increasing demand for prenatal and genetic testing and rising focus on laboratory consolidation to support market growth 154
TABLE 121 SPAIN: KEY MACROINDICATORS 155
TABLE 122 SPAIN: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 155
TABLE 123 SPAIN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 124 SPAIN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 156
TABLE 125 SPAIN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 156
TABLE 126 SPAIN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 156
TABLE 127 SPAIN: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 157
10.3.7 RUSSIA 157
10.3.7.1 Increasing access to quality healthcare and growing incidence of lifestyle and infectious diseases to drive market 157
TABLE 128 RUSSIA: KEY MACROINDICATORS 157
TABLE 129 RUSSIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 158
TABLE 130 RUSSIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 158
TABLE 131 RUSSIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 158
TABLE 132 RUSSIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 159
TABLE 133 RUSSIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 159
TABLE 134 RUSSIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 159
10.3.8 REST OF EUROPE 160
TABLE 135 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 160
TABLE 136 REST OF EUROPE: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 160
TABLE 137 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 161
TABLE 138 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 161
TABLE 139 REST OF EUROPE: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 140 REST OF EUROPE: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 162

10.4 ASIA PACIFIC 162
FIGURE 34 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET SNAPSHOT 163
10.4.1 ASIA PACIFIC: RECESSION IMPACT 164
TABLE 141 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 164
TABLE 142 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 164
TABLE 143 ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 165
TABLE 144 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 165
TABLE 145 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 165
TABLE 146 ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 166
TABLE 147 ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 166
10.4.2 JAPAN 166
10.4.2.1 Well-developed healthcare system and demand for improvements in quality of IVD test results to drive market 166
TABLE 148 JAPAN: KEY MACROINDICATORS 167
TABLE 149 JAPAN: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 167
TABLE 150 JAPAN: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 167
TABLE 151 JAPAN: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 168
TABLE 152 JAPAN: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 168
TABLE 153 JAPAN: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 168
TABLE 154 JAPAN: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 169
10.4.3 CHINA 169
10.4.3.1 Growing access to modern healthcare and government support to boost market growth 169
TABLE 155 CHINA: KEY MACROINDICATORS 170
TABLE 156 CHINA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 170
TABLE 157 CHINA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 158 CHINA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 171
TABLE 159 CHINA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 171
TABLE 160 CHINA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 171
TABLE 161 CHINA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 172
10.4.4 INDIA 172
10.4.4.1 Rising need to secure NABL accreditations to drive demand for quality controls 172
FIGURE 35 INDIA: INCREASING NUMBER OF LABORATORIES WITH NABL ACCREDITATIONS, 2012–2022 172
TABLE 162 INDIA: KEY MACROINDICATORS 173
TABLE 163 INDIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 173
TABLE 164 INDIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 174
TABLE 165 INDIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 174
TABLE 166 INDIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 174
TABLE 167 INDIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 175
TABLE 168 INDIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 175
10.4.5 AUSTRALIA 175
10.4.5.1 Initiatives to enhance access to healthcare and improve infrastructure to propel market growth 175
TABLE 169 AUSTRALIA: KEY MACROINDICATORS 176
TABLE 170 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 176
TABLE 171 AUSTRALIA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 177
TABLE 172 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 177
TABLE 173 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 177
TABLE 174 AUSTRALIA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 178
TABLE 175 AUSTRALIA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 178
10.4.6 SOUTH KOREA 178
10.4.6.1 Rising healthcare expenditure and growing number of hospitals to drive market 178
TABLE 176 SOUTH KOREA: KEY MACROINDICATORS 179
TABLE 177 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 179
TABLE 178 SOUTH KOREA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 179
TABLE 179 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 180
TABLE 180 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 180
TABLE 181 SOUTH KOREA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 180
TABLE 182 SOUTH KOREA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 181
10.4.7 REST OF ASIA PACIFIC 181
TABLE 183 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 182
TABLE 184 REST OF ASIA PACIFIC: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 185 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 183
TABLE 186 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 183
TABLE 187 REST OF ASIA PACIFIC: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 183
TABLE 188 REST OF ASIA PACIFIC: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 184
10.5 LATIN AMERICA 184
10.5.1 LATIN AMERICA: RECESSION IMPACT 184
TABLE 189 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 185
TABLE 190 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 185
TABLE 191 LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 185
TABLE 192 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 186
TABLE 193 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 186
TABLE 194 LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 186
TABLE 195 LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 187
10.5.2 BRAZIL 187
10.5.2.1 Brazil dominates Latin American IVD quality controls market 187
TABLE 196 BRAZIL: KEY MACROINDICATORS 188
TABLE 197 BRAZIL: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 188
TABLE 198 BRAZIL: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 188
TABLE 199 BRAZIL: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 189
TABLE 200 BRAZIL: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 189
TABLE 201 BRAZIL: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 189
TABLE 202 BRAZIL: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 190
10.5.3 MEXICO 190
10.5.3.1 Increasing number of accredited clinical laboratories to support market growth 190
TABLE 203 MEXICO: KEY MACROINDICATORS 190
TABLE 204 MEXICO: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 191
TABLE 205 MEXICO: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 191
TABLE 206 MEXICO: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 191
TABLE 207 MEXICO: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 192
TABLE 208 MEXICO: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 192
TABLE 209 MEXICO: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 192
10.5.4 REST OF LATIN AMERICA 193
TABLE 210 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 193
TABLE 211 REST OF LATIN AMERICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 193
TABLE 212 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 194
TABLE 213 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 194
TABLE 214 REST OF LATIN AMERICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 194
TABLE 215 REST OF LATIN AMERICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 195
10.6 MIDDLE EAST AND AFRICA 195
10.6.1 MIDDLE EAST AND AFRICA: RECESSION IMPACT 195
10.6.2 RISING CANCER INCIDENCE TO DRIVE MARKET 195
TABLE 216 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY PRODUCT AND SERVICE, 2020–2027 (USD MILLION) 196
TABLE 217 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROL PRODUCTS MARKET, BY TYPE, 2020–2027 (USD MILLION) 196
TABLE 218 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 197
TABLE 219 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY MANUFACTURER TYPE, 2020–2027 (USD MILLION) 197
TABLE 220 MIDDLE EAST AND AFRICA: THIRD-PARTY CONTROLS MARKET, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 221 MIDDLE EAST AND AFRICA: IVD QUALITY CONTROLS MARKET, BY END USER, 2020–2027 (USD MILLION) 198

11 COMPETITIVE LANDSCAPE 199
11.1 OVERVIEW 199
11.2 STRATEGIES ADOPTED BY KEY PLAYERS 199
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 200
FIGURE 36 REVENUE ANALYSIS OF TOP PLAYERS IN IVD QUALITY CONTROLS MARKET 200
11.4 MARKET SHARE ANALYSIS 200
FIGURE 37 IVD QUALITY CONTROLS MARKET SHARE, BY KEY PLAYER, 2021 201
11.5 COMPETITIVE BENCHMARKING 202
TABLE 222 PRODUCT PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET 202
TABLE 223 TECHNOLOGY PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET 203
TABLE 224 MANUFACTURER TYPE PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET 204
TABLE 225 END-USER PORTFOLIO ANALYSIS: IVD QUALITY CONTROLS MARKET 205
11.6 REGIONAL FOOTPRINT OF KEY PLAYERS 206
TABLE 226 REGIONAL REVENUE MIX: IVD QUALITY CONTROLS MARKET 206
11.7 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS 207
11.7.1 STARS 208
11.7.2 EMERGING LEADERS 208
11.7.3 PERVASIVE PLAYERS 208
11.7.4 PARTICIPANTS 208
FIGURE 38 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION QUADRANT FOR KEY PLAYERS (2021) 209
11.8 R&D EXPENDITURE 210
FIGURE 39 IVD QUALITY CONTROLS MARKET: R&D EXPENDITURE (USD MILLION), 2021 210
11.9 COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES 211
11.9.1 PROGRESSIVE COMPANIES 211
11.9.2 DYNAMIC COMPANIES 211
11.9.3 STARTING BLOCKS 211
11.9.4 RESPONSIVE COMPANIES 211
FIGURE 40 IVD QUALITY CONTROLS MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES (2021) 212
11.10 COMPETITIVE SITUATIONS AND TRENDS 213
11.10.1 DEALS 213
TABLE 227 DEALS, JANUARY 2019–JANUARY 2023 213
11.10.2 PRODUCT LAUNCHES 214
TABLE 228 PRODUCT LAUNCHES, JANUARY 2019–JANUARY 2023 214
11.10.3 OTHER DEVELOPMENTS 215
TABLE 229 OTHER DEVELOPMENTS, JANUARY 2019–JANUARY 2023 215

12 COMPANY PROFILES 216
(Business overview, Products and services offered, Recent developments & MnM View)*
12.1 KEY PLAYERS 216
12.1.1 BIO-RAD LABORATORIES, INC. 216
TABLE 230 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 216
FIGURE 41 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 217
12.1.2 THERMO FISHER SCIENTIFIC, INC. 231
TABLE 231 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW 231
FIGURE 42 THERMO FISHER SCIENTIFIC, INC.: COMPANY SNAPSHOT (2021) 232
12.1.3 RANDOX LABORATORIES LTD. 240
TABLE 232 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW 240
12.1.4 LGC LIMITED 247
TABLE 233 LGC LIMITED: BUSINESS OVERVIEW 247
FIGURE 43 LGC LIMITED: COMPANY SNAPSHOT (2021) 248
12.1.5 ROCHE DIAGNOSTICS 255
TABLE 234 ROCHE DIAGNOSTICS: BUSINESS OVERVIEW 255
FIGURE 44 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2021) 256
12.1.6 ABBOTT LABORATORIES 258
TABLE 235 ABBOTT LABORATORIES: BUSINESS OVERVIEW 258
FIGURE 45 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2021) 259
12.1.7 SIEMENS HEALTHINEERS 262
TABLE 236 SIEMENS HEALTHINEERS: BUSINESS OVERVIEW 262
FIGURE 46 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2021) 263
12.1.8 QUIDEL CORPORATION 265
TABLE 237 QUIDEL CORPORATION: BUSINESS OVERVIEW 265
FIGURE 47 QUIDEL CORPORATION: COMPANY SNAPSHOT (2021) 265
12.1.9 DANAHER CORPORATION 268
TABLE 238 DANAHER CORPORATION: BUSINESS OVERVIEW 268
FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2021) 269
12.1.10 SYSMEX CORPORATION 271
TABLE 239 SYSMEX CORPORATION: BUSINESS OVERVIEW 271
FIGURE 49 SYSMEX CORPORATION: COMPANY SNAPSHOT (2021) 271
12.1.11 ORTHO-CLINICAL DIAGNOSTICS, INC. 274
TABLE 240 ORTHO-CLINICAL DIAGNOSTICS, INC.: BUSINESS OVERVIEW 274
FIGURE 50 ORTHO-CLINICAL DIAGNOSTICS, INC.: COMPANY SNAPSHOT (2021) 275
12.1.12 BIO-TECHNE CORPORATION 277
TABLE 241 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW 277
FIGURE 51 BIO-TECHNE CORPORATION: COMPANY SNAPSHOT (2021) 278
12.1.13 SEEGENE INC. 284
TABLE 242 SEEGENE INC.: BUSINESS OVERVIEW 284
FIGURE 52 SEEGENE INC.: COMPANY SNAPSHOT (2020) 285
12.1.14 QNOSTICS 289
TABLE 243 QNOSTICS: BUSINESS OVERVIEW 289
12.1.15 MICROBIOLOGICS, INC. 292
TABLE 244 MICROBIOLOGICS: BUSINESS OVERVIEW 292
12.1.16 ZEPTOMETRIX CORPORATION 296
TABLE 245 ZEPTOMETRIX CORPORATION: BUSINESS OVERVIEW 296
12.1.17 FORTRESS DIAGNOSTICS 299
TABLE 246 FORTRESS DIAGNOSTICS: BUSINESS OVERVIEW 299
12.1.18 MICROBIX BIOSYSTEMS INC. 302
TABLE 247 MICROBIX BIOSYSTEMS INC.: BUSINESS OVERVIEW 302
FIGURE 53 MICROBIX BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2021) 303
12.1.19 GRIFOLS, S.A. 308
TABLE 248 GRIFOLS, S.A.: BUSINESS OVERVIEW 308
FIGURE 54 GRIFOLS, S.A.: COMPANY SNAPSHOT (2021) 309
12.1.20 ALPHA-TEC SYSTEMS, INC. 311
TABLE 249 ALPHA-TEC SYSTEMS, INC.: BUSINESS OVERVIEW 311
12.2 OTHER PLAYERS 312
12.2.1 HELENA LABORATORIES CORPORATION 312
TABLE 250 HELENA LABORATORIES CORPORATION: BUSINESS OVERVIEW 312
12.2.2 STRECK, INC. 315
TABLE 251 STRECK, INC.: BUSINESS OVERVIEW 315
12.2.3 MAINE MOLECULAR QUALITY CONTROLS, INC. 317
TABLE 252 MAINE MOLECULAR QUALITY CONTROLS, INC.: BUSINESS OVERVIEW 317
12.2.4 SUN DIAGNOSTICS, LLC 320
TABLE 253 SUN DIAGNOSTICS, LLC: BUSINESS OVERVIEW 320
12.2.5 SERO AS 321
TABLE 254 SERO AS: BUSINESS OVERVIEW 321
*Details on Business overview, Products and services offered, Recent developments & MnM View might not be captured in case of unlisted companies.
13 APPENDIX 323
13.1 DISCUSSION GUIDE 323
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 328
13.3 CUSTOMIZATION OPTIONS 330
13.4 RELATED REPORTS 330
13.5 AUTHOR DETAILS 331

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の体外診断用医薬品(IVD)品質管理市場(~2027):ソース別(血漿、全血、尿)、技術別、製造業者別、エンドユーザー別(In Vitro Diagnostics (IVD) Quality Control Market by Source (Plasma, Whole Blood, Urine), Technology (Immunoassay, Hematology, Microbiology, Coagulation), Manufacturer (Third party, OEM), End Users (Hospitals, Lab, Research) - Global Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆